Anti-CRP/ PTX1 functional antibody
Anti-CRP/ PTX1 functional antibody for cell culture, ELISA & in-vivo assay
Go to CRP/CRP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE0824-Ab-1/ GM-Tg-hg-SE0824-Ab-2 | Anti-Human CRP monoclonal antibody | Human |
GM-Tg-rg-SE0824-Ab-1/ GM-Tg-rg-SE0824-Ab-2 | Anti-Rat CRP monoclonal antibody | Rat |
GM-Tg-mg-SE0824-Ab-1/ GM-Tg-mg-SE0824-Ab-2 | Anti-Mouse CRP monoclonal antibody | Mouse |
GM-Tg-cynog-SE0824-Ab-1/ GM-Tg-cynog-SE0824-Ab-2 | Anti-Cynomolgus/ Rhesus macaque CRP monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE0824-Ab-1/ GM-Tg-felg-SE0824-Ab-2 | Anti-Feline CRP monoclonal antibody | Feline |
GM-Tg-cang-SE0824-Ab-1/ GM-Tg-cang-SE0824-Ab-2 | Anti-Canine CRP monoclonal antibody | Canine |
GM-Tg-bovg-SE0824-Ab-1/ GM-Tg-bovg-SE0824-Ab-2 | Anti-Bovine CRP monoclonal antibody | Bovine |
GM-Tg-equg-SE0824-Ab-1/ GM-Tg-equg-SE0824-Ab-2 | Anti-Equine CRP monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE0824-Ab-1/ GM-Tg-hg-SE0824-Ab-2; GM-Tg-rg-SE0824-Ab-1/ GM-Tg-rg-SE0824-Ab-2; GM-Tg-mg-SE0824-Ab-1/ GM-Tg-mg-SE0824-Ab-2; GM-Tg-cynog-SE0824-Ab-1/ GM-Tg-cynog-SE0824-Ab-2; GM-Tg-felg-SE0824-Ab-1/ GM-Tg-felg-SE0824-Ab-2; GM-Tg-cang-SE0824-Ab-1/ GM-Tg-cang-SE0824-Ab-2; GM-Tg-bovg-SE0824-Ab-1/ GM-Tg-bovg-SE0824-Ab-2; GM-Tg-equg-SE0824-Ab-1/ GM-Tg-equg-SE0824-Ab-2 |
Products Name | Anti-CRP monoclonal antibody |
Format | mab |
Target Name | CRP |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody, Diagnostic target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-CRP benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE0824-Ag-1 | Recombinant multi-species CRP/ PTX1 protein |
Cytokine | GM-Tg-g-SE0824-Ag-1 | C-reactive protein, pentraxin-related (CRP) protein |
ORF Viral Vector | pGMAAV000165 | human CRP AAV plasmid |
ORF Viral Vector | pGMAP000461 | Human CRP Adenovirus plasmid |
ORF Viral Vector | vGMAAV000165 | human CRP AAV particle |
ORF Viral Vector | vGMAP000461 | Human CRP Adenovirus particle |
ORF Viral Vector | pGMLPm000921 | mouse Crp Lentivirus plasmid |
ORF Viral Vector | vGMLPm000921 | mouse Crp Lentivirus particle |
Target information
Target ID | GM-SE0824 |
Target Name | CRP |
Gene ID | 1401,12944,25419,719454,488629,101093079,527553,100057752 |
Gene Symbol and Synonyms | Aa1249,Ab1-341,Ab2-196,Ac1-114,Ac1262,Ac2-069,Ba2-693,CRP,PTX1 |
Uniprot Accession | P02741,P48199 |
Uniprot Entry Name | CRP_HUMAN,CRP_RAT |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Diagnostics Biomarker, Cytokine Target |
Disease | Breast Cancer, cardiovascular disease, Pregnant state, pancreatic, renal, gastrointestinal, tissue damage, Acute coronary syndromes, Cardiovascular Diseases, cardiovascular events, Cardiovascular Events, cardiovascular outcome, coronary ischemic events, infections, Infectious disease: falciparum malaria, Infectious disease: AIDS, Infectious disease: ATL, Infectious disease: hepatitis, Infectious disease: herpes simplex, Infectious disease: syphilis, Infectious disease: TB, Inflammation, Inflammatory reactions, lymphoma, Mediastinal lympadenopathy, melanoma, myeloma, ovarian, Sepsis, neonatal infections, Non-small cell lung carcinoma |
Gene Ensembl | ENSG00000132693 |
Target Classification | N/A |
The target: CRP, gene name: CRP, also named as PTX1. The protein encoded by this gene belongs to the pentraxin family which also includes serum amyloid P component protein and pentraxin 3. Pentraxins are involved in complement activation and amplification via communication with complement initiation pattern recognition molecules, but also complement regulation via recruitment of complement regulators. The encoded protein has a calcium dependent ligand binding domain with a distinctive flattened beta-jellyroll structure. It exists in two forms as either a pentamer in circulation or as a nonsoluble monomer in tissues. It is involved in several host defense related functions based on its ability to recognize foreign pathogens and damaged cells of the host and to initiate their elimination by interacting with humoral and cellular effector systems in the blood. Consequently, the level of this protein in plasma increases greatly during acute phase response to tissue injury, infection, or other inflammatory stimuli. Elevated expression of the encoded protein is associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. [provided by RefSeq, Aug 2020].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.